News

Latest

Oct 5, 2021
About 275,000 low-income adults are now eligible for coverage under Medicaid expansion in Missouri, the Centers for Medicare & Medicaid Services announced.
Oct 5, 2021
The U.S. Chamber of Commerce and 21 other organizations, including the AHA, urged Congress to maintain the current legal and regulatory framework for evaluating mergers and acquisitions. 
Oct 5, 2021
Anthem, the country’s second-biggest health insurance company, is behind on billions of dollars in payments owed to hospitals and doctors because of onerous new reimbursement rules, computer problems and mishandled claims, says a Kaiser Health News article that is spotlighted in USA Today.
Oct 5, 2021
Kentucky, Maine and New Mexico have completed their transition from the federally facilitated marketplace to their own state-based marketplaces for the 2022 plan year, the Department of Health and Human Services announced.
Oct 5, 2021
Johnson & Johnson announced its request that the Food and Drug Administration amend the current emergency use authorization for the J&J COVID-19 vaccine to include a booster dose.
Oct 5, 2021
AstraZeneca said it has requested an emergency use authorization from the Food and Drug Administration for its long-acting antibody combination for the prevention of symptomatic COVID-19.
Oct 5, 2021
The Food and Drug Administration authorized the emergency use of a new over-the-counter COVID-19 antigen test. Unlike most antigen tests for at-home use, the new test does not require serial testing, FDA said.
Oct 5, 2021
COVID-19 vaccinations may have helped prevent an estimated 265,000 COVID-19 infections, 107,000 hospitalizations and 39,000 deaths among Medicare beneficiaries between January and May 2021, according to a study released by the Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation.
Oct 4, 2021
The upcoming Accelerating Health Equity Conference is seeking participants who can help lead discussions via breakout sessions or poster presentations.
Oct 4, 2021
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Oct. 1 announced that it will meet later this month for a pair of significant discussions on COVID-19 vaccines.